Total Payments
$5,916
2024 Payments
$1,777
Companies
34
Transactions
316
Medicare Patients
2,375
Medicare Billing
$240,966
Payment Breakdown by Category
Food & Beverage$5,844 (98.8%)
Education$71.23 (1.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,844 | 314 | 98.8% |
| Education | $71.23 | 2 | 1.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $1,054 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $564.33 | 36 | $0 (2024) |
| HARMONY BIOSCIENCES LLC | $486.01 | 18 | $0 (2024) |
| United Therapeutics Corporation | $370.12 | 20 | $0 (2024) |
| GENZYME CORPORATION | $319.75 | 19 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $314.35 | 22 | $0 (2024) |
| Actelion Pharmaceuticals US, Inc. | $290.72 | 19 | $0 (2024) |
| Insmed, Inc. | $290.23 | 13 | $0 (2024) |
| Genentech USA, Inc. | $264.84 | 18 | $0 (2024) |
| La Jolla Pharmaceutical Company | $262.14 | 11 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,777 | 90 | AstraZeneca Pharmaceuticals LP ($305.75) |
| 2023 | $1,940 | 101 | AstraZeneca Pharmaceuticals LP ($295.93) |
| 2022 | $1,196 | 67 | AstraZeneca Pharmaceuticals LP ($294.11) |
| 2021 | $1,003 | 58 | AstraZeneca Pharmaceuticals LP ($158.34) |
All Payment Transactions
316 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Respiratory | ||||||
| 12/17/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: RESPIRATORY | ||||||
| 12/16/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $19.46 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 12/09/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.67 | General |
| Category: RESPIRATORY | ||||||
| 12/02/2024 | ABBVIE INC. | AVYCAZ (Drug), TEFLARO | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/26/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: RESPIRATORY | ||||||
| 11/18/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/13/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Immunology | ||||||
| 11/06/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: Respiratory | ||||||
| 10/30/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/29/2024 | Merck Sharp & Dohme LLC | ZERBAXA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: INFECTIOUS DISEASE | ||||||
| 10/28/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $14.90 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/21/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: RESPIRATORY | ||||||
| 10/18/2024 | Harmony Biosciences Llc | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $30.23 | General |
| Category: Narcoplepsy | ||||||
| 10/17/2024 | United Therapeutics Corporation | TYVASO (Drug) | Food and Beverage | In-kind items and services | $22.80 | General |
| Category: Pulmonary Arterial Hypertension and Pulmonary Hypertension with Interstitial Lung Disease | ||||||
| 10/08/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Respiratory | ||||||
| 10/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.79 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/01/2024 | Novartis Pharmaceuticals Corporation | XOLAIR (Drug) | Food and Beverage | In-kind items and services | $20.42 | General |
| Category: Pulmonary/Respiratory Diseases | ||||||
| 09/26/2024 | Actelion Pharmaceuticals US, Inc. | UPTRAVI (Drug), OPSUMIT | Food and Beverage | In-kind items and services | $13.58 | General |
| Category: Cardiology | ||||||
| 09/25/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $27.67 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 807 | 1,031 | $144,785 | $56,121 |
| 2022 | 2 | 324 | 1,089 | $166,282 | $49,225 |
| 2021 | 3 | 506 | 1,400 | $213,446 | $64,766 |
| 2020 | 3 | 738 | 1,559 | $233,150 | $70,853 |
Total Patients
2,375
Total Services
5,079
Medicare Billing
$240,966
Procedure Codes
11
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 585 | 626 | $81,380 | $35,275 | 43.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 207 | 390 | $59,280 | $19,586 | 33.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $4,125 | $1,260 | 30.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 312 | 1,076 | $163,552 | $48,562 | 29.7% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 12 | 13 | $2,730 | $663.37 | 24.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 461 | 1,353 | $205,656 | $62,809 | 30.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 19 | 21 | $4,410 | $1,418 | 32.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 26 | 26 | $3,380 | $538.85 | 15.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 483 | 1,280 | $194,560 | $61,113 | 31.4% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 228 | 250 | $32,500 | $7,838 | 24.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 27 | 29 | $6,090 | $1,903 | 31.2% |
About Errol Hook, ACNP
Errol Hook, ACNP is a Acute Care healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225017445.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Errol Hook, ACNP has received a total of $5,916 in payments from pharmaceutical and medical device companies, with $1,777 received in 2024. These payments were reported across 316 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,844).
As a Medicare-enrolled provider, Hook has provided services to 2,375 Medicare beneficiaries, totaling 5,079 services with total Medicare billing of $240,966. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Ad
Practice Information
- Specialty Acute Care
- Location Memphis, TN
- Active Since 01/16/2006
- Last Updated 11/12/2019
- Taxonomy Code 363LA2100X
- Entity Type Individual
- NPI Number 1225017445
Products in Payments
- FASENRA (Biological) $616.65
- DUPIXENT (Biological) $501.76
- WAKIX (Drug) $437.88
- TRELEGY ELLIPTA (Drug) $363.40
- Arikayce (Drug) $269.66
- Xolair (Biological) $211.89
- TYVASO (Drug) $211.18
- GIAPREZA (Drug) $208.69
- OFEV (Drug) $194.38
- TEZSPIRE (Biological) $186.41
- UPTRAVI (Drug) $184.04
- ZERBAXA (Drug) $165.61
- Prolastin-C Liquid (Biological) $161.07
- ORENITRAM (Drug) $158.94
- NUCALA (Biological) $156.06
- YUPELRI (Drug) $123.73
- SYMBICORT (Drug) $121.64
- STIOLTO RESPIMAT (Drug) $119.97
- Yupelri (Drug) $108.89
- OPSUMIT (Drug) $106.68
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Acute Care Doctors in Memphis
Anne Alexandrov, Phd, Agacnp-Bc, PHD, AGACNP-BC
Acute Care — Payments: $109,301
Acute Care $109,301
Amanda Allen, Np, NP
Acute Care — Payments: $6,980
Acute Care $6,980
Jennifer O'dell, Acnp, Bc, ACNP, BC
Acute Care — Payments: $5,987
Acute Care $5,987
Mrs. Lauren Plyler, Ag-Acnp-Bc, AG-ACNP-BC
Acute Care — Payments: $5,396
Acute Care $5,396
Mrs. Raquel Vaughan, Np, NP
Acute Care — Payments: $4,451
Acute Care $4,451
Robert Pegram, Np, NP
Acute Care — Payments: $4,355
Acute Care $4,355